Closed · CDC-RFA-PS15-1501 · CFDA 93.116 · Discretionary

Tuberculosis Elimination and Laboratory Cooperative Agreement (CoAg)

Federal grant opportunity posted by Centers for Disease Control and Prevention, cataloged on Grants.gov.

$119K-$8.3M
Award range
Closed
Status
September 4, 2014
Close date
62
Expected awards

The verdict

Tuberculosis Elimination and Laboratory Cooperative Agreement (CoAg) is a closed discretionary listing from Centers for Disease Control and Prevention that offered $118,760 -- $8,304,252 across 62 expected awards. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 1,727 other opportunities from Centers for Disease Control and Prevention.

$119K-$8.3M
award range
Closed
application status
62
expected awards
93.116
CFDA program

Archived opportunity record

Tuberculosis Elimination and Laboratory Coope… is closed (last close September 4, 2014). The parent program page for CFDA 93.116 is the reliable place to catch re-announcements. Centers for Disease Control and Prevention still indexes 1,727 other opportunities here.

According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.

Deadline tracker

Application window closed

Closed September 4, 2014

Posted Jun 20 Closes Sep 4

Est. Total Funding

$385,601,610

Expected Awards

62

Instrument

Cooperative Agreement

Description

The purpose of the Tuberculosis (TB) Elimination Cooperative Agreement (CoAg) funds is to assist the current efforts of state, local, and territorial TB programs to prevent, control, and eventually eliminate TB in the United States. Financial assistance is provided to TB programs to augment current local contributions for TB prevention and control activities; developing human resources through improved training, education, communications, and information dissemination; and strengthening laboratory capacity to ensure that timely and reliable TB laboratory services be available to healthcare providers and TB controllers.

Catch-all / unrestricted eligibility mark · CDC-RFA-PS15-1501

Grants.gov marks Tuberculosis Elimination and Laboratory Coope… with a catch-all / unrestricted eligibility code (Others (see official listing text)). Read the official announcement text for the real applicant filter — the code alone is not a door list. The extract does not mark applicant cost-sharing as required. Instrument: Cooperative Agreement. Funding-activity code maps to Health (HL). This eligibility-code string dominates the Centers for Disease Control and Prevention book (1,452 peers, 84% of 1,728).

Code 25
Others (see official listing text)

Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.

Official Listing on Grants.gov

View full details, application forms, and submission instructions.

View on Grants.gov

Agency Contact

CDC Procurement and Grants Office (PGO) Technical Information Management Section (TIMS) Phone: 770-488-2700

What to do next

Tuberculosis Elimination and Laboratory Coope… is closed; use the parent program and agency catalog for the next funding cycle.

  • Parent CFDA 93.116 may publish future NOFOs under the same assistance listing. Open program
  • Grants for Preventive Medicine and Public Hea… indexes 0 Grants.gov listings in this extract. Program profile
  • Centers for Disease Control and Prevention lists 1,727 other indexed opportunities on PlainGrants. Agency catalog

Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.

Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.

Data sourced from the SAM.gov Assistance Listings and Grants.gov. See our methodology for details. Retrieved and formatted by PlainGrants